BIMI INTERNATIONAL MEDICAL I (BIMI) Fundamental Analysis & Valuation

NASDAQ:BIMI • US05552Q3011

Current stock price

0.31 USD
-0.17 (-35.42%)
At close:
0.3115 USD
+0 (+0.48%)
After Hours:

This BIMI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. BIMI Profitability Analysis

1.1 Basic Checks

  • BIMI had negative earnings in the past year.
  • BIMI had a negative operating cash flow in the past year.
BIMI Yearly Net Income VS EBIT VS OCF VS FCFBIMI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 0 -10M -20M -30M

1.2 Ratios

  • BIMI has a worse Return On Assets (-30.51%) than 83.48% of its industry peers.
  • The Return On Equity of BIMI (-122.77%) is worse than 77.39% of its industry peers.
Industry RankSector Rank
ROA -30.51%
ROE -122.77%
ROIC N/A
ROA(3y)-54.49%
ROA(5y)-50.22%
ROE(3y)-292.5%
ROE(5y)-218.85%
ROIC(3y)N/A
ROIC(5y)N/A
BIMI Yearly ROA, ROE, ROICBIMI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 -100 -200 -300 -400 -500

1.3 Margins

  • BIMI has a Gross Margin of 41.01%. This is in the better half of the industry: BIMI outperforms 69.57% of its industry peers.
  • In the last couple of years the Gross Margin of BIMI has grown nicely.
  • BIMI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 41.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y8.8%
BIMI Yearly Profit, Operating, Gross MarginsBIMI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 -500 -1K -1.5K -2K -2.5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. BIMI Health Analysis

2.1 Basic Checks

  • BIMI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, BIMI has more shares outstanding
  • BIMI has a better debt/assets ratio than last year.
BIMI Yearly Shares OutstandingBIMI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 1M 2M 3M
BIMI Yearly Total Debt VS Total AssetsBIMI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M

2.2 Solvency

  • BIMI has an Altman-Z score of -3.03. This is a bad value and indicates that BIMI is not financially healthy and even has some risk of bankruptcy.
  • BIMI's Altman-Z score of -3.03 is on the low side compared to the rest of the industry. BIMI is outperformed by 86.09% of its industry peers.
  • A Debt/Equity ratio of 0.13 indicates that BIMI is not too dependend on debt financing.
  • BIMI has a better Debt to Equity ratio (0.13) than 73.04% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Altman-Z -3.03
ROIC/WACCN/A
WACC5.72%
BIMI Yearly LT Debt VS Equity VS FCFBIMI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 10M -10M 20M

2.3 Liquidity

  • BIMI has a Current Ratio of 1.21. This is a normal value and indicates that BIMI is financially healthy and should not expect problems in meeting its short term obligations.
  • BIMI has a Current ratio of 1.21. This is comparable to the rest of the industry: BIMI outperforms 41.74% of its industry peers.
  • A Quick Ratio of 0.86 indicates that BIMI may have some problems paying its short term obligations.
  • BIMI has a Quick ratio of 0.86. This is in the lower half of the industry: BIMI underperforms 69.57% of its industry peers.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 0.86
BIMI Yearly Current Assets VS Current LiabilitesBIMI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. BIMI Growth Analysis

3.1 Past

  • BIMI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 96.66%, which is quite impressive.
  • BIMI shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.31%.
  • BIMI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.81% yearly.
EPS 1Y (TTM)96.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70.72%
Revenue 1Y (TTM)14.31%
Revenue growth 3Y319.71%
Revenue growth 5Y6.81%
Sales Q2Q%-65.48%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BIMI Yearly Revenue VS EstimatesBIMI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2019 2020 2021 2022 5M 10M 15M 20M

More info and screens

Find the best growth stocksShow best growing peers

0

4. BIMI Valuation Analysis

4.1 Price/Earnings Ratio

  • BIMI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BIMI Price Earnings VS Forward Price EarningsBIMI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BIMI Per share dataBIMI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1 -1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BIMI Dividend Analysis

5.1 Amount

  • BIMI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

BIMI Fundamentals: All Metrics, Ratios and Statistics

BIMI INTERNATIONAL MEDICAL I

NASDAQ:BIMI (8/21/2024, 8:07:30 PM)

After market: 0.3115 +0 (+0.48%)

0.31

-0.17 (-35.42%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)06-24
Earnings (Next)11-25
Inst Owners0.16%
Inst Owner Change0%
Ins Owners210.74%
Ins Owner Change0%
Market Cap2.07M
Revenue(TTM)10.25M
Net Income(TTM)-10.69M
Analysts0
Price TargetN/A
Short Float %4.63%
Short Ratio0.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.42
P/FCF N/A
P/OCF N/A
P/B 0.5
P/tB 0.7
EV/EBITDA N/A
EPS(TTM)-1.58
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)-0.16
OCFYN/A
SpS0.73
BVpS0.62
TBVpS0.44
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -30.51%
ROE -122.77%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 41.01%
FCFM N/A
ROA(3y)-54.49%
ROA(5y)-50.22%
ROE(3y)-292.5%
ROE(5y)-218.85%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y8.8%
F-Score6
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.21
Quick Ratio 0.86
Altman-Z -3.03
F-Score6
WACC5.72%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)96.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70.72%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)14.31%
Revenue growth 3Y319.71%
Revenue growth 5Y6.81%
Sales Q2Q%-65.48%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y75.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y46.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y33.35%
OCF growth 3YN/A
OCF growth 5YN/A

BIMI INTERNATIONAL MEDICAL I / BIMI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of BIMI INTERNATIONAL MEDICAL I (BIMI) stock?

ChartMill assigns a fundamental rating of 1 / 10 to BIMI.


What is the valuation status of BIMI INTERNATIONAL MEDICAL I (BIMI) stock?

ChartMill assigns a valuation rating of 0 / 10 to BIMI INTERNATIONAL MEDICAL I (BIMI). This can be considered as Overvalued.


Can you provide the profitability details for BIMI INTERNATIONAL MEDICAL I?

BIMI INTERNATIONAL MEDICAL I (BIMI) has a profitability rating of 1 / 10.


What is the financial health of BIMI INTERNATIONAL MEDICAL I (BIMI) stock?

The financial health rating of BIMI INTERNATIONAL MEDICAL I (BIMI) is 2 / 10.